journal article·2025-03-10

Locally Delivered Hydrogel with Sustained Release of Flavonol Compound Kaempferol Mitigates Inflammatory Progression of Periodontitis and Enhances the Gut Microflora Composition in Rats

Ningli Li, Mingzhen Yang, Miaomiao Feng, Xiaoran Xu, Yingying Li, Yonghong Zhang, Cory J. Xian, Tiejun Li, Yuankun Zhai

Publisher page

Abstract

OBJECTIVE: This study aimed to investigate the effects of a sustained-release composite containing gelatin methacryloyl (Gel) and kaempferol (Ka, K) on experimental periodontitis symptoms in rats. METHODS: Forty 6-week-old male rats were randomly assigned to four treatment groups in a specific pathogen-free (SPF) environment: Control group (C), periodontitis model group (M), Gel alone group (G), and Gel_Ka composite-treated group (G_K). Treatment effects on the periodontal status of bilateral maxillary second molars in each rat group were assessed by micro-CT imaging and histology. Immunohistochemistry staining was employed to examine the effects on expression levels of inflammatory factors IL-6 and MMP9 (associated with M1 macrophages) and of the anti-inflammatory factor CD206 (associated with M2 macrophages). Additionally, treatment effects on oral and intestinal microbial communities were analyzed through 16S rDNA sequencing. RESULTS: Local injection treatment with the G_K composite hydrogel effectively suppressed alveolar bone resorption and reduced periodontal attachment loss and inflammation infiltration in rats with periodontitis. It reduced the expression of inflammatory factors MMP9 and IL-6 but increased the anti-inflammatory factor CD206, and it also increased the abundance of gut microbial communities producing short-chain fatty acids. CONCLUSION: Local treatment with the sustained-release G_K hydrogel composite demonstrates a substantial antiperiodontitis effect in rats by locally attenuating inflammation and is associated with enhancing the microbial composition of intestinal flora, thus aiding in mitigating the inflammatory progression of experimental periodontitis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Endodontics and Root Canal Treatments · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Stomatology

Henan University

Kaifeng Key Laboratory of Periodontal Tissue Engineering

Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital)

Department of Orthopaedics

The second Hospital of Shanxi Medical University

UniSA Clinical and Health Sciences

University of South Australia

Department of Oral Pathology

Peking University School and Hospital of Stomatology

Funding

Science and Technology Department of Henan Province · Foundation of Science and Technology Department of Kaifeng City · Foundation for Young Scholar in School of Stomatology of Henan University · Natural Science Foundation of Education Department of Henan Province · Key Lab of Medical Molecular Cell Biology of Shanxi Province, Shanxi University

References (82)

Show source-provided references
1. 10.1111/jcpe.1350610.1111/jcpe.13506 ↗
2. Wang H. · Lancet · 2020 · 396 · 116010.1016/S0140-6736(20)30977-6 ↗
3. CDC researchers find close to half of American adults have periodontitis J. Can. Dent. Assoc. 2012; Vol. 78, p c136.
4. 10.1111/jcpe.1273210.1111/jcpe.12732 ↗
5. 10.1039/D4LP00001C10.1039/D4LP00001C ↗
6. 10.4103/2230-973X.10439410.4103/2230-973X.104394 ↗
7. 10.1128/JB.01254-0610.1128/JB.01254-06 ↗
8. 10.3390/diagnostics701000710.3390/diagnostics7010007 ↗
9. 10.3389/fmicb.2015.0011910.3389/fmicb.2015.00119 ↗
10. 10.14740/wjon159610.14740/wjon1596 ↗
11. 10.47102/annals-acadmedsg.V34N1p11110.47102/annals-acadmedsg.V34N1p111 ↗
12. 10.1007/s10266-006-0060-610.1007/s10266-006-0060-6 ↗
13. 10.1111/prd.1222110.1111/prd.12221 ↗
14. 10.1034/j.1600-0757.2001.22250102.x10.1034/j.1600-0757.2001.22250102.x ↗
15. 10.1902/jop.1989.60.7.40210.1902/jop.1989.60.7.402 ↗
16. 10.1111/j.1600-051X.1993.tb01762.x10.1111/j.1600-051X.1993.tb01762.x ↗
17. 10.3389/fdmed.2023.116356210.3389/fdmed.2023.1163562 ↗
18. 10.1111/j.1600-0757.2012.00450.x10.1111/j.1600-0757.2012.00450.x ↗
19. 10.1902/annals.2003.8.1.11510.1902/annals.2003.8.1.115 ↗
20. 10.2147/DDDT.S31978610.2147/DDDT.S319786 ↗
21. 10.1111/jre.1208510.1111/jre.12085 ↗
22. 10.1177/002203451668571110.1177/0022034516685711 ↗
23. 10.1034/j.1600-051x.2002.290208.x10.1034/j.1600-051x.2002.290208.x ↗
24. 10.4049/jimmunol.173.5.351410.4049/jimmunol.173.5.3514 ↗
25. 10.1007/s11883-017-0696-410.1007/s11883-017-0696-4 ↗
26. 10.4049/jimmunol.160085910.4049/jimmunol.1600859 ↗
27. 10.1016/j.jep.2023.11727910.1016/j.jep.2023.117279 ↗
28. 10.1155/2021/547794110.1155/2021/5477941 ↗
29. 10.1177/002203451879727510.1177/0022034518797275 ↗
30. 10.1016/j.fsi.2019.12.02510.1016/j.fsi.2019.12.025 ↗
31. 10.1016/j.intimp.2016.04.02410.1016/j.intimp.2016.04.024 ↗
32. 10.22038/IJBMS.2018.31997.769010.22038/IJBMS.2018.31997.7690 ↗
33. 10.1080/13880209.2017.134718810.1080/13880209.2017.1347188 ↗
34. 10.1021/jf000892m10.1021/jf000892m ↗
35. 10.36721/PJPS.2021.34.1.SP.403-409.110.36721/PJPS.2021.34.1.SP.403-409.1 ↗
36. 10.1016/j.jep.2009.04.02410.1016/j.jep.2009.04.024 ↗
37. 10.1155/2007/4567310.1155/2007/45673 ↗
38. 10.2174/13895571179530533510.2174/138955711795305335 ↗
39. 10.1186/s12906-016-1320-910.1186/s12906-016-1320-9 ↗
40. 10.1371/journal.pone.008088310.1371/journal.pone.0080883 ↗
41. 10.1016/j.lfs.2020.11814310.1016/j.lfs.2020.118143 ↗
42. 10.5051/jpis.2016.46.2.8410.5051/jpis.2016.46.2.84 ↗
43. 10.3390/molecules2503051610.3390/molecules25030516 ↗
44. 10.1016/j.ijpharm.2019.11865910.1016/j.ijpharm.2019.118659 ↗
45. 10.1902/jop.2000.71.1.12510.1902/jop.2000.71.1.125 ↗
46. 10.1080/10408398.2021.189833310.1080/10408398.2021.1898333 ↗
47. 10.1002/ptr.563110.1002/ptr.5631 ↗
48. 10.3109/10717544.2014.93553110.3109/10717544.2014.935531 ↗
49. 10.1021/acsbiomaterials.8b0065810.1021/acsbiomaterials.8b00658 ↗
50. 10.2174/15672010778215121410.2174/156720107782151214 ↗
51. 10.3390/jfb1508023310.3390/jfb15080233 ↗
52. 10.1016/j.actbio.2022.03.04610.1016/j.actbio.2022.03.046 ↗
53. 10.1097/SAP.0b013e31819b6c5210.1097/SAP.0b013e31819b6c52 ↗
54. 10.3390/gels810063010.3390/gels8100630 ↗
55. 10.1007/s10856-019-6333-810.1007/s10856-019-6333-8 ↗
56. 10.1002/adhm.20230039510.1002/adhm.202300395 ↗
57. 10.1021/acsbiomaterials.2c0112710.1021/acsbiomaterials.2c01127 ↗
58. 10.1021/acsomega.2c0729110.1021/acsomega.2c07291 ↗
59. 10.1002/jemt.2462210.1002/jemt.24622 ↗
60. 10.1002/adhm.20200052710.1002/adhm.202000527 ↗
61. 10.1186/s13287-023-03567-210.1186/s13287-023-03567-2 ↗
62. 10.1007/s10522-007-9083-910.1007/s10522-007-9083-9 ↗
63. 10.1016/j.ijbiomac.2014.10.05510.1016/j.ijbiomac.2014.10.055 ↗
64. 10.1111/prd.1212110.1111/prd.12121 ↗
65. 10.1016/j.phrs.2015.05.00210.1016/j.phrs.2015.05.002 ↗
66. 10.1186/1749-8546-7-1010.1186/1749-8546-7-10 ↗
67. 10.1016/j.lfs.2020.11814310.1016/j.lfs.2020.118143 ↗
68. 10.1208/s12249-019-1318-y10.1208/s12249-019-1318-y ↗
69. 10.1111/cbdd.1451910.1111/cbdd.14519 ↗
70. 10.3389/fgene.2023.107963110.3389/fgene.2023.1079631 ↗
71. 10.1155/2018/785809410.1155/2018/7858094 ↗
72. 10.1021/acsnano.3c1037610.1021/acsnano.3c10376 ↗
73. 10.1111/jre.1328810.1111/jre.13288 ↗
74. 10.1016/j.pharmthera.2016.04.00710.1016/j.pharmthera.2016.04.007 ↗
75. 10.3390/nu1612192310.3390/nu16121923 ↗
76. 10.3389/fcimb.2024.137142910.3389/fcimb.2024.1371429 ↗
77. 10.1016/j.ahj.2021.05.00210.1016/j.ahj.2021.05.002 ↗
78. 10.1038/ismej.2012.17410.1038/ismej.2012.174 ↗
79. 10.1111/jre.1234410.1111/jre.12344 ↗
80. 10.1016/j.expneurol.2020.11317610.1016/j.expneurol.2020.113176 ↗
81. 10.1034/j.1600-051X.1999.260501.x10.1034/j.1600-051X.1999.260501.x ↗
82. 10.1111/adj.1229410.1111/adj.12294 ↗